Your browser doesn't support javascript.
loading
The Unfolded Protein Response: A Novel Therapeutic Target for Poor Prognostic BRAF Mutant Colorectal Cancer.
Forsythe, Nicholas; Refaat, Alaa; Javadi, Arman; Khawaja, Hajrah; Weir, Jessica-Anne; Emam, Heba; Allen, Wendy L; Burkamp, Frank; Popovici, Vlad; Jithesh, Puthen V; Isella, Claudio; Labonte, Melissa J; Mills, Ian G; Johnston, Patrick G; Van Schaeybroeck, Sandra.
Afiliación
  • Forsythe N; Drug Resistance Group, Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Science, Queen's University Belfast, Belfast, United Kingdom.
  • Refaat A; Drug Resistance Group, Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Science, Queen's University Belfast, Belfast, United Kingdom.
  • Javadi A; Drug Resistance Group, Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Science, Queen's University Belfast, Belfast, United Kingdom.
  • Khawaja H; Drug Resistance Group, Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Science, Queen's University Belfast, Belfast, United Kingdom.
  • Weir JA; Drug Resistance Group, Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Science, Queen's University Belfast, Belfast, United Kingdom.
  • Emam H; Drug Resistance Group, Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Science, Queen's University Belfast, Belfast, United Kingdom.
  • Allen WL; Drug Resistance Group, Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Science, Queen's University Belfast, Belfast, United Kingdom.
  • Burkamp F; Almac Discovery Laboratories, Centre for Precision Therapeutics, Belfast, United Kingdom.
  • Popovici V; Research Centre for Toxic Compounds in the Environment, Faculty of Science, Masarykova Univerzita, Czech Republic.
  • Jithesh PV; Division of Biomedical Informatics, Sidra Medical and Research Center, Education City North Campus, Doha, Qatar.
  • Isella C; Department of Oncology, University of Torino School of Medicine, Candiolo, Torino, Italy.
  • Labonte MJ; Candiolo Cancer Institute-FPO IRCCS, Candiolo, Torino, Italy.
  • Mills IG; Drug Resistance Group, Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Science, Queen's University Belfast, Belfast, United Kingdom.
  • Johnston PG; Drug Resistance Group, Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Science, Queen's University Belfast, Belfast, United Kingdom.
  • Van Schaeybroeck S; Drug Resistance Group, Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Science, Queen's University Belfast, Belfast, United Kingdom.
Mol Cancer Ther ; 17(6): 1280-1290, 2018 06.
Article en En | MEDLINE | ID: mdl-29483217
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Proteínas Proto-Oncogénicas B-raf / Inhibidores de Proteínas Quinasas / Respuesta de Proteína Desplegada / Mutación Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Proteínas Proto-Oncogénicas B-raf / Inhibidores de Proteínas Quinasas / Respuesta de Proteína Desplegada / Mutación Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos